ArticleThe oncologist2026

Optimal duration of adjuvant targeted-immunotherapy in patients with initially unresectable hepatocellular carcinoma with portal vein tumor thrombus following successful conversion therapy.

Lei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.